Efficacy and Safety of Serplulimab Combined With Etoposide and Cisplatin as Neoadjuvant Therapy in Limited-Stage Small-Cell Carcinoma of the Esophageal

NCT07155122 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

15

Enrollment

OTHER_GOV

Sponsor class

Conditions

Small-Cell Carcinoma of the Esophageal

Interventions

DRUG: Drug: Serplulimab
DRUG: Drug: Etoposide
DRUG: Drug: Chemotherapy

Sponsor

Fujian Cancer Hospital